Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


23.05.2022

1 Ann Neurol
2 BMC Neurol
1 Exp Brain Res
2 J Neurol Neurosurg Psychiatry
11 Mov Disord
5 Neurobiol Dis
1 Neurology
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. SHEN J, Amari N, Zack R, Skrinak RT, et al
    Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson's Disease.
    Ann Neurol. 2022 May 20. doi: 10.1002/ana.26410.
    PubMed         Abstract available


    BMC Neurol

  2. WAGNER L, Hauptmann B, Hoffmann AK, Jochems N, et al
    Evaluation of an individualized, tablet-based physiotherapy training programme for patients with Parkinson's disease: the ParkProTrain study, a quasi-randomised controlled trial.
    BMC Neurol. 2022;22:176.
    PubMed         Abstract available

  3. KAWASHIMA S, Matsukawa N
    Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study.
    BMC Neurol. 2022;22:175.
    PubMed         Abstract available


    Exp Brain Res

  4. PILLAI L, Glover A, Virmani T
    A study of turn bias in people with idiopathic Parkinson's disease.
    Exp Brain Res. 2022 May 12. pii: 10.1007/s00221-022-06378.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  5. XU SS, Lee WL, Perera T, Sinclair NC, et al
    Can brain signals and anatomy refine contact choice for deep brain stimulation in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2022 May 19. pii: jnnp-2021-327708.
    PubMed         Abstract available

  6. VIJIARATNAM N, Lawton M, Heslegrave AJ, Guo T, et al
    Combining biomarkers for prognostic modelling of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2022 May 16. pii: jnnp-2021-328365.
    PubMed         Abstract available


    Mov Disord

  7. MAHLKNECHT P, Foltynie T, Limousin P, Poewe W, et al
    How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
    Mov Disord. 2022 May 12. doi: 10.1002/mds.29052.
    PubMed         Abstract available

  8. YE R, O'Callaghan C, Rua C, Hezemans FH, et al
    Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders.
    Mov Disord. 2022 May 16. doi: 10.1002/mds.29072.
    PubMed         Abstract available

  9. SMEYNE RJ, Eells JB, Chatterjee D, Byrne M, et al
    COVID-19 infection enhances susceptibility to oxidative-stress induced parkinsonism.
    Mov Disord. 2022 May 17. doi: 10.1002/mds.29116.
    PubMed         Abstract available

  10. FOFFANI G
    An Exponential Rather Than Multistep Model of Parkinson's Disease Pathogenesis.
    Mov Disord. 2022;37:1105-1106.
    PubMed        

  11. SUBRAMANIAN I, Mathur S, Oosterbaan A, Flanagan R, et al
    Reply to: "Promoting Gender Inclusivity: A questionnaire for Women's Health Factors in Parkinson's Disease".
    Mov Disord. 2022;37:1113.
    PubMed        

  12. DARWEESH SKL, Vermeulen R, Bloem BR, Peters S, et al
    Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health Implications.
    Mov Disord. 2022;37:883-885.
    PubMed        

  13. SCORZA FA, de Almeida AG, Scorza CA, Finsterer J, et al
    Parkinson's Disease, Premature Mortality, and Amygdala.
    Mov Disord. 2022;37:1110-1111.
    PubMed        

  14. RAO SC, Pattipati S, Salim A, Gutierrez N, et al
    Promoting Gender Inclusivity: A Questionnaire for Women's Health Factors in Parkinson's Disease.
    Mov Disord. 2022;37:1112-1113.
    PubMed        

  15. LAANSMA MA, Bright JK, Jahanshad N, Thompson PM, et al
    Reply to: "Parkinson's Disease, Premature Mortality, and Amygdala".
    Mov Disord. 2022;37:1111-1112.
    PubMed        

  16. GRISANTI S, Ferri L, Cavallieri F, Fioravanti V, et al
    Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations.
    Mov Disord. 2022;37:1117-1118.
    PubMed        

  17. MACIAS-GARCIA D, Perinan MT, Munoz-Delgado L, Jesus S, et al
    Reply to: "Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations".
    Mov Disord. 2022;37:1119-1120.
    PubMed        


    Neurobiol Dis

  18. KEENEY MT, Hoffman EK, Farmer K, Bodle CR, et al
    NADPH oxidase 2 activity in Parkinson's disease.
    Neurobiol Dis. 2022 May 13:105754. doi: 10.1016/j.nbd.2022.105754.
    PubMed         Abstract available

  19. TIAN Y, Pan L, Yuan X, Xiong M, et al
    7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the alpha-synuclein 1-103 transgenic mice.
    Neurobiol Dis. 2022;169:105736.
    PubMed         Abstract available

  20. RUSSO I, Bubacco L, Greggio E
    LRRK2 as a target for modulating immune system responses.
    Neurobiol Dis. 2022;169:105724.
    PubMed         Abstract available

  21. BURMEISTER AR, Gordevicius J, Paul EN, Houck C, et al
    Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring.
    Neurobiol Dis. 2022;169:105720.
    PubMed         Abstract available

  22. PAMIES D, Wiersma D, Katt ME, Zhao L, et al
    Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.
    Neurobiol Dis. 2022;169:105719.
    PubMed         Abstract available


    Neurology

  23. AVENALI M, Vaghi G, De Icco R, Grillo V, et al
    Pearls & Oy-sters: Marionette walk in Parkinson's disease: a rare dyskinetic-dystonic gait pattern complication improved by visual cueing.
    Neurology. 2022 May 18. pii: WNL.0000000000200714.
    PubMed         Abstract available


    PLoS One

  24. GRAMOTNEV DK, Gramotnev G, Gramotnev A, Summers MJ, et al
    Path analysis of biomarkers for cognitive decline in early Parkinson's disease.
    PLoS One. 2022;17:e0268379.
    PubMed         Abstract available

  25. TROISI LOPEZ E, Minino R, Sorrentino P, Manzo V, et al
    Sensitivity to gait improvement after levodopa intake in Parkinson's disease: A comparison study among synthetic kinematic indices.
    PLoS One. 2022;17:e0268392.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: